Stealth BioTherapeutics Corp logo
Stealth BioTherapeutics Corp MITO

Annual report 2021
added 12-23-2023

report update icon

Stealth BioTherapeutics Corp Market Cap 2011-2026 | MITO

As of April 09, 2026 Stealth BioTherapeutics Corp has a market cap of $ 23.9 M


Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]

Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.

This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.

Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.

Annual Market Cap Stealth BioTherapeutics Corp

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
450 M 47.9 M 78.9 M - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
450 M 47.9 M 192 M

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.

Market Cap of other stocks in the Biotechnology industry

Issuer Market Cap Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
315 M - 2.43 % $ 254 M germanyGermany
Acorda Therapeutics Acorda Therapeutics
ACOR
16.7 M - -24.86 % $ 820 K usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
76.4 M - - $ 86.2 M usaUSA
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
3.19 B $ 22.56 2.13 % $ 3.74 B usaUSA
AlloVir AlloVir
ALVR
13.1 M - 4.14 % $ 49.1 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
22.1 M - - $ 10.1 M usaUSA
Applied Therapeutics Applied Therapeutics
APLT
541 M - - $ 8.42 M usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
334 M $ 1.43 3.62 % $ 368 M usaUSA
argenx SE argenx SE
ARGX
13.8 B $ 785.07 2.57 % $ 25 B niderlandNiderland
I-Mab I-Mab
IMAB
127 M - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
33.6 B - - $ 40.3 B usaUSA
Genfit SA Genfit SA
GNFT
168 B - 2.54 % $ 160 B franceFrance
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
40.8 B $ 327.25 2.42 % $ 42.9 B usaUSA
Biophytis SA Biophytis SA
BPTS
549 M - -13.47 % $ 169 M franceFrance
Aytu BioScience Aytu BioScience
AYTU
15.8 M $ 2.66 3.5 % $ 16.7 M usaUSA
AVROBIO AVROBIO
AVRO
56.3 M - 1083.1 % $ 745 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
7.72 M - - $ 7.46 M israelIsrael
AstraZeneca PLC AstraZeneca PLC
AZN
81.2 B - - $ 96.9 B britainBritain
Midatech Pharma plc Midatech Pharma plc
MTP
79 M - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
28.9 M - -1.52 % $ 24.7 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
253 B - 0.49 % $ 251 B cayman-islandsCayman-islands
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
895 M $ 3.9 3.7 % $ 9.38 B australiaAustralia
CymaBay Therapeutics CymaBay Therapeutics
CBAY
3.43 B - - $ 3.45 B usaUSA
Advaxis Advaxis
ADXS
1.87 M - -9.65 % $ 45.9 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
1.25 B $ 20.4 -0.87 % $ 954 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
467 M $ 4.18 1.21 % $ 447 M usaUSA
Avid Bioservices Avid Bioservices
CDMO
423 M - - $ 789 M usaUSA
Cidara Therapeutics Cidara Therapeutics
CDTX
148 M - - $ 1.41 B usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
2.83 B - - - russiaRussia
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
3.44 B $ 24.61 5.76 % $ 3.13 B usaUSA
Cabaletta Bio Cabaletta Bio
CABA
283 M $ 3.09 0.65 % $ 310 M usaUSA
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
160 M - - $ 169 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
41.4 M - 5.93 % $ 314 M canadaCanada
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
52.7 M - - $ 231 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
14.1 K - -10.17 % $ 12.2 K usaUSA
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
103 M - - $ 401 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
724 M - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
32.8 M - - $ 26.5 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
322 M $ 1.49 9.56 % $ 397 M britainBritain
CTI BioPharma Corp. CTI BioPharma Corp.
CTIC
551 M - - $ 1.2 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
19.6 M - 1.93 % $ 17.4 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
2.32 M - -45.71 % $ 1.2 M canadaCanada
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
109 K - -4.36 % $ 27 M usaUSA
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
1.2 B - - $ 2.18 B usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
3.25 B - - $ 3.67 B usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
1.73 B - - $ 2.02 B usaUSA
Forte Biosciences Forte Biosciences
FBRX
335 M $ 26.27 0.38 % $ 340 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
3.53 B - - $ 867 M germanyGermany
Akari Therapeutics, Plc Akari Therapeutics, Plc
AKTX
8.08 B $ 3.88 2.11 % $ 261 B britainBritain
Akouos Akouos
AKUS
172 M - 0.23 % $ 488 M usaUSA